Filing Details
- Accession Number:
- 0001735276-20-000090
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-14 16:03:49
- Reporting Period:
- 2020-07-13
- Accepted Time:
- 2020-07-14 16:03:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1620743 | Laurie Keating | 675 West Kendall Street Henri A. Termeer Square Cambridge MA 02142 | Evp, Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-07-13 | 1,941 | $42.22 | 16,433 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-07-13 | 23,809 | $77.40 | 40,242 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-07-13 | 3,750 | $119.13 | 43,992 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-07-13 | 6,250 | $119.13 | 50,242 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-07-13 | 4,482 | $157.16 | 45,760 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-13 | 2,323 | $158.27 | 43,437 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-13 | 1,061 | $159.22 | 42,376 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-13 | 14,236 | $160.52 | 28,140 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-13 | 15,618 | $161.32 | 12,522 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-07-13 | 9,530 | $162.24 | 2,992 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Performance Stock Option 2017 (right to buy) | Disposition | 2020-07-13 | 3,750 | $0.00 | 3,750 | $119.13 |
Common Stock | Stock Option (right to buy) | Disposition | 2020-07-13 | 1,941 | $0.00 | 1,941 | $42.22 |
Common Stock | Stock Option (right to buy) | Disposition | 2020-07-13 | 23,809 | $0.00 | 23,809 | $77.40 |
Common Stock | Stock Option (right to buy) | Disposition | 2020-07-13 | 6,250 | $0.00 | 6,250 | $119.13 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,416 | 2019-11-22 | 2028-03-01 | No | 4 | M | Direct |
4,311 | 2026-12-20 | No | 4 | M | Direct | |
18,191 | 2024-09-22 | No | 4 | M | Direct | |
7,500 | 2028-02-28 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 434 | Indirect | by Managed Account |
Footnotes
- All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2020.
- Sale prices ranged from $156.86 to $157.66.
- Sale prices ranged from $157.74 to $158.62.
- Sale prices ranged from $158.82 to $159.64.
- Sale prices ranged from $159.89 to $160.86.
- Sale prices ranged from $160.90 to $161.89.
- Sale prices ranged from $161.91 to $162.80.
- Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
- The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to the remaining shares ratably at the end of each three-month period thereafter over the following thirty-three (33) months